02162.HK
Keymed Biosciences Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 67.05
+0.22%Leverage
- Debt / equity
- 0.17x
- Net debt / equity
- -0.41x
- Debt / assets
- 0.12x
- Debt / EBITDA
- -1.33x
- Net debt / EBITDA
- 3.17x
Liquidity & coverage
- Current ratio
- 4.83x
- Quick ratio
- 4.55x
- Cash ratio
- 3.97x
- Interest coverage
- -39.41x
- EBITDA / interest
- -33.56x
- Working capital
- HKD 3.7B
Cash & dividend
- FCF / debt
- -1.23x
- Cash flow / debt
- -0.86x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026